Glioblastoma multiforme versus pleomorphic xanthoastrocytoma with anaplastic features in the pathological diagnosis: a case report

被引:7
作者
Yamada, Shoko M. [1 ]
Murakami, Hideki [1 ]
Tomita, Yusuke [1 ]
Nakane, Makoto [1 ]
Shibui, Soichiro [1 ]
Takahashi, Mikiko [2 ]
Kawamoto, Masashi [2 ]
机构
[1] Teikyo Univ, Mizonokuchi Hosp, Dept Neurosurg, Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan
[2] Teikyo Univ, Mizonokuchi Hosp, Dept Diagnost Pathol, Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan
关键词
Pleomorphic xanthoastrocytoma; Glioblastoma; Anaplastic features; Ki-67; index;
D O I
10.1186/s13000-016-0514-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Pleomorphic xanthoastrocytoma (PXA) with anaplastic features should be strictly distinguished from glioblastoma multiforme (GBM). Case presentation: A case of PXA that was initially diagnosed as GBM is presented. A 42-year-old man visited our clinic because of right hemiparesis and total aphasia. Head magnetic resonance imaging demonstrated enhanced multiple cystic lesions in the left temporal lobe suggesting an intra-parenchymal brain tumor. The lesion was partially removed and GBM with a Ki-67 index of 20 % was diagnosed by pathological examination of the resected specimen. Despite receiving radiation and chemotherapy, the patient died 6 months after the first admission. At autopsy, the boundary between the tumor and normal brain tissue was clear. Large parts of the tumor demonstrated typical features of PXA, including pleomorphism, clear xanthomatous cells with foamy cytoplasm, positive silver staining, and a Ki-67 index of less than 1 %. Discussion and conclusions: GBM should be diagnosed only when the majority of the tumor cells are undifferentiated. Although the operative specimen appeared typical GBM histologically, the diagnosis of GBM was subsequently excluded by the autopsy finding that much of the tumor had the characteristic features of a benign PXA. Therefore, the final diagnosis in this case was PXA with anaplastic features. PXA with anaplastic features should be carefully distinguished from GBM to facilitate appropriate decisions concerning treatment.
引用
收藏
页数:5
相关论文
共 14 条
[1]   Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: Implications for differential diagnosis [J].
Gelpi, E ;
Popovic, M ;
Preusser, M ;
Budka, H ;
Hainfellner, J .
NEUROPATHOLOGY, 2005, 25 (03) :241-246
[2]  
Giannini C, 1999, CANCER, V85, P2033, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2033::AID-CNCR22>3.0.CO
[3]  
2-Z
[4]   Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types [J].
Hirose, T. ;
Ishizawa, K. ;
Sugiyama, K. ;
Kageji, T. ;
Ueki, K. ;
Kannuki, S. .
HISTOPATHOLOGY, 2008, 52 (02) :183-193
[5]   Treatment Response to Preoperative Anthracycline-Based Chemotherapy in Locally Advanced Breast Cancer: The Relevance of Proliferation and Apoptosis Rates [J].
Kanjer, Ksenija ;
Tatic, Svetislav ;
Neskovic-Konstantinovic, Zora ;
Abu Rabi, Zaki ;
Nikolic-Vukosavljevic, Dragica .
PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (03) :577-588
[6]  
Lakhani S.R., WHO Classification of Tumours of the Breast, VFourth
[7]  
Leonard N, 1998, HISTOPATHOLOGY, V32, P375
[8]   Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial [J].
Stupp, Roger ;
Hegi, Monika E. ;
Mason, Warren P. ;
van den Bent, Martin J. ;
Taphoorn, Martin J. B. ;
Janzer, Robert C. ;
Ludwin, Samuel K. ;
Allgeier, Anouk ;
Fisher, Barbara ;
Belanger, Karl ;
Hau, Peter ;
Brandes, Alba A. ;
Gijtenbeek, Johanna ;
Marosi, Christine ;
Vecht, Charles J. ;
Mokhtari, Karima ;
Wesseling, Pieter ;
Villa, Salvador ;
Eisenhauer, Elizabeth ;
Gorlia, Thierry ;
Weller, Michael ;
Lacombe, Denis ;
Cairncross, J. Gregory ;
Mirimanoff, Rene-Olivier .
LANCET ONCOLOGY, 2009, 10 (05) :459-466
[9]  
Tihan T., 2011, YOUMANS NEUROLOGICAL, P1108
[10]  
Travis W., 1999, Histological Typing of Lung and Pleural Tumours